R.I. Ketchell

576 total citations
25 papers, 213 citations indexed

About

R.I. Ketchell is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, R.I. Ketchell has authored 25 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in R.I. Ketchell's work include Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (4 papers) and Respiratory viral infections research (3 papers). R.I. Ketchell is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (4 papers) and Respiratory viral infections research (3 papers). R.I. Ketchell collaborates with scholars based in United Kingdom, United States and India. R.I. Ketchell's co-authors include Brian O’Connor, Mark I. Allenby, A. Wright, Philip Lumley, Domenico Spina, J. Duckers, Lindsay George, Penny Agent, Margaret E. Hodson and Khin M. Gyi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

R.I. Ketchell

25 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.I. Ketchell United Kingdom 8 165 117 20 16 13 25 213
Soma Datta United States 6 95 0.6× 123 1.1× 18 0.9× 17 1.1× 9 0.7× 9 288
Ji‐Su Shim South Korea 7 65 0.4× 113 1.0× 15 0.8× 33 2.1× 9 0.7× 22 178
Jasmin Honkamäki Finland 6 119 0.7× 182 1.6× 59 3.0× 28 1.8× 5 0.4× 8 238
Sharon Brouwer Netherlands 5 93 0.6× 96 0.8× 15 0.8× 40 2.5× 8 0.6× 9 226
Mehtap Haktanır Abul Türkiye 6 56 0.3× 73 0.6× 25 1.3× 23 1.4× 3 0.2× 15 196
S. Palkonen Spain 2 61 0.4× 72 0.6× 17 0.8× 5 0.3× 7 0.5× 4 100
Hanna Hisinger‐Mölkänen Finland 8 158 1.0× 238 2.0× 82 4.1× 32 2.0× 7 0.5× 17 319
Sherell Thornton‐Thompson United States 3 45 0.3× 63 0.5× 13 0.7× 12 0.8× 5 0.4× 3 95
Karin Dahl Assing Denmark 6 81 0.5× 107 0.9× 16 0.8× 13 0.8× 6 0.5× 9 122
Paul Marsden United Kingdom 13 403 2.4× 377 3.2× 26 1.3× 29 1.8× 8 0.6× 40 489

Countries citing papers authored by R.I. Ketchell

Since Specialization
Citations

This map shows the geographic impact of R.I. Ketchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Ketchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Ketchell more than expected).

Fields of papers citing papers by R.I. Ketchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.I. Ketchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Ketchell. The network helps show where R.I. Ketchell may publish in the future.

Co-authorship network of co-authors of R.I. Ketchell

This figure shows the co-authorship network connecting the top 25 collaborators of R.I. Ketchell. A scholar is included among the top collaborators of R.I. Ketchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.I. Ketchell. R.I. Ketchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Christopher, et al.. (2019). Assessment of Sexual Reproductive Health Knowledge Amongst Patients with Cystic Fibrosis. Sexuality and Disability. 37(1). 15–23. 2 indexed citations
2.
Plant, Barry J., D.G. Downey, Joe Eustace, et al.. (2017). A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis. Journal of Cystic Fibrosis. 16(6). 695–701. 5 indexed citations
3.
Ketchell, R.I.. (2017). Telemedicine is the way forward for the management of cystic fibrosis – the case in favour. Paediatric Respiratory Reviews. 26. 19–21. 13 indexed citations
4.
Proud, David, et al.. (2017). 344 Which grip device to grip? A comparison of hand grip strength dynamometers in adult patients with cystic fibrosis. Journal of Cystic Fibrosis. 16. S151–S151. 1 indexed citations
5.
Proud, David, et al.. (2016). 196 Change in body composition pre and post lung transplant in adult CF patients. Journal of Cystic Fibrosis. 15. S101–S101. 1 indexed citations
6.
Proud, David, et al.. (2016). 191 Test–retest reliability of bioelectrical impedance and hand grip strength over 1 year in adult patients with cystic fibrosis. Journal of Cystic Fibrosis. 15. S99–S100. 1 indexed citations
7.
Evans, Louis, et al.. (2015). Hyperpharmacotherapy in ageing cystic fibrosis patients: The first report of an atypical hip fracture. SHILAP Revista de lepidopterología. 16. 148–150. 4 indexed citations
8.
Stone, Mike, et al.. (2015). 202 Bone mineral density and fractures at the All Wales Adult CF Centre (AWACFC). Journal of Cystic Fibrosis. 14. S110–S110. 2 indexed citations
9.
Lau, David C.W., et al.. (2015). 135 Transformational care at the All Wales Adult CF Centre (AWACFC) – the impact of ivacaftor (Kalydeco®) one year on. Journal of Cystic Fibrosis. 14. S92–S92. 2 indexed citations
10.
Roberts, Robin, et al.. (2014). Retinal screening of patients with cystic fibrosis-related diabetes in Wales — A real eye opener. Journal of Cystic Fibrosis. 14(2). 282–284. 14 indexed citations
11.
Lau, Denys T., et al.. (2014). WS9.6 The All Wales Adult Cystic Fibrosis Centre (AWACFC) Virtual Instruction of Exercise With Technology to Enhance Care – VIEWTEC Programme. Journal of Cystic Fibrosis. 13. S20–S20. 1 indexed citations
12.
Salek, Sam, et al.. (2012). Do Patient-Reported Outcomes Have a Role in the Management of Patients with Cystic Fibrosis?. Frontiers in Pharmacology. 3. 38–38. 9 indexed citations
13.
Marson, Ben A., et al.. (2011). P242 Bone density and testosterone levels in male cystic fibrosis patients. Thorax. 66(Suppl 4). A166–A166. 3 indexed citations
14.
Duckers, J., et al.. (2010). Overweight/obese CF patients, cause for concern?. Journal of Cystic Fibrosis. 9. S87–S87. 1 indexed citations
15.
Ketchell, R.I., Sy Ha, Penny Agent, Khin M. Gyi, & Margaret E. Hodson. (2009). Predicting survival in end-stage cystic fibrosis. Respiratory Medicine. 103(10). 1441–1447. 15 indexed citations
16.
Ketchell, R.I., et al.. (2002). Dose-related effects of formoterol on airway responsiveness to adenosine 5′‐monophosphate and histamine. European Respiratory Journal. 19(4). 611–616. 24 indexed citations
18.
Allenby, Mark I., et al.. (2002). The changes in airway inflammatory cells following inhalation of lipopolysaccharide (LPS). Journal of Allergy and Clinical Immunology. 109(1). S30–S31. 4 indexed citations
19.
Ketchell, R.I., et al.. (2002). Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. Journal of Allergy and Clinical Immunology. 110(4). 603–606. 79 indexed citations
20.
Ketchell, R.I.. (2001). Japanese Gardens in a Weekend. Medical Entomology and Zoology. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026